Cyrus Therapeutics
PrivateLast Round
Series C
Nov 11, 2025
Total Funding Raised
$47.74M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cyrus Therapeutics is a biotechnology company that develops small molecule medicines and next-generation anticancer drugs targeting undruggable proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyrus Therapeutics Comparables
Compare Cyrus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pin Therapeutics | 89% | |
| Ubix Therapeutics | 87% | |
| Illimis Therapeutics | 85% |
Cyrus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 11, 2025 | ||||
| Series B | Jan 27, 2022 | ||||
| Series A | Sep 28, 2020 |
Cyrus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paratus Investment | Series A, Series B |
| Timefolio Asset Management | Series A, Series B |
| Mirae Asset Capital | Series B |
| Kolon Investment | Series A, Series B |
| Mirae Asset Venture Investment | Series B |
| Atinum Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 39% MoM, reaching 3.9K.
- May 12, 2026
Monthly visitors increased 44% MoM.
Cyrus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cyrus Therapeutics's valuation, stock price, and market status.
Is Cyrus Therapeutics a public or private company?
Cyrus Therapeutics is a private company.
What is the current stock price of Cyrus Therapeutics?
Cyrus Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Cyrus Therapeutics worth (valuation)?
Valuation information for Cyrus Therapeutics is not publicly available.
Can I buy Cyrus Therapeutics stock?
Cyrus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cyrus Therapeutics's last funding round?
Cyrus Therapeutics's most recent funding round was Series C on November 11, 2025.
Who are the main investors in Cyrus Therapeutics?
Key investors in Cyrus Therapeutics include Paratus Investment, Timefolio Asset Management, Mirae Asset Capital, Kolon Investment, Mirae Asset Venture Investment.
Will Cyrus Therapeutics IPO soon?
No public IPO plans have been announced for Cyrus Therapeutics.
How can I track Cyrus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cyrus Therapeutics's secondary market activity and sign up for updates.